The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia

Authors

Eric H. Kim, Washington University School of Medicine in St. Louis
John A. Brockman, Washington University School of Medicine in St. Louis
Gerald L. Andriole, Washington University School of Medicine in St. Louis

Journal

Asian Journal of Urology

Publication Date

2018

Volume

5

Issue

1

Inclusive Pages

28-32

Document Type

Open Access Publication

DOI

10.1016/j.ajur.2017.11.005

Rights and Permissions

Kim EH, Brockman JA, Andriole GL (2018) The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia. Asian Journal of Urology, 5(1):28-32. https://doi.org/10.1016/j.ajur.2017.11.005 Copyright 2018 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Kim, Eric H.; Brockman, John A.; and Andriole, Gerald L., "The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia." Asian Journal of Urology. 5, 1. 28-32. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/6625